$TRXDW
Stock $trxdw

$trxdw Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921011716 Filed on May 11, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$2.083M	$600.0K
YoY Change	247.17%	-72.49%
Cost Of Revenue	$3.112M	$1.738M
YoY Change	79.06%	-29.55%
Gross Profit	-$1.029M	-$1.138M
YoY Change	-9.58%	297.9%
Gross Profit Margin	-49.4%	-189.67%
Selling, General & Admin	$7.045M	$7.602M
YoY Change	-7.33%	-37.86%
% of Gross Profit
Research & Development	$4.215M	$3.934M
YoY Change	7.14%	-30.43%
% of Gross Profit
Depreciation & Amortization	$802.0K	$570.0K
YoY Change	40.7%	-5.0%
% of Gross Profit
Operating Expenses	$14.38M	$16.01M
YoY Change	-10.18%	-10.48%
Operating Profit	-$15.41M	-$17.15M
YoY Change	-10.14%	-21.77%
Interest Expense	$7.000K	$0.00
YoY Change		-100.0%
% of Operating Profit
Other Income/Expense, Net	-$1.965M	-$143.0K
YoY Change	1274.13%	-88.17%
Pretax Income	-$17.38M	-$17.30M
YoY Change	0.48%	-25.24%
Income Tax	-$40.00K	-$697.0K
% Of Pretax Income
Net Earnings	-$17.34M	-$16.60M
YoY Change	4.47%	-26.31%
Net Earnings / Revenue	-832.45%	-2766.33%
Basic Earnings Per Share	-$0.08
Diluted Earnings Per Share	-$84.59K	-$574.2K
COMMON SHARES
Basic Shares Outstanding	205.0M	46.09M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$165.2M	$21.82M
YoY Change	657.45%	-54.93%
Cash & Equivalents	$165.2M	$21.82M
Short-Term Investments
Other Short-Term Assets	$3.593M	$7.341M
YoY Change	-51.06%	-28.11%
Inventory	$11.18M	$9.829M
Prepaid Expenses		$1.412M
Receivables	$2.306M	$951.0K
Other Receivables	$0.00	$2.635M
Total Short-Term Assets	$182.3M	$39.94M
YoY Change	356.53%	-51.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.179M	$6.060M
YoY Change	51.47%	2.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$193.0K	$2.168M
YoY Change	-91.1%	27.91%
Total Long-Term Assets	$41.29M	$44.29M
YoY Change	-6.78%	-67.08%
TOTAL ASSETS
Total Short-Term Assets	$182.3M	$39.94M
Total Long-Term Assets	$41.29M	$44.29M
Total Assets	$223.6M	$84.23M
YoY Change	165.48%	-61.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.327M	$4.047M
YoY Change	-42.5%	-14.91%
Accrued Expenses	$3.830M	$8.026M
YoY Change	-52.28%	13.94%
Deferred Revenue	$892.0K	$903.0K
YoY Change	-1.22%	-44.19%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.459M
YoY Change
Total Short-Term Liabilities	$9.508M	$13.05M
YoY Change	-27.13%	-33.2%
LONG-TERM LIABILITIES
Long-Term Debt	$356.0K	$0.00
YoY Change		-100.0%
Other Long-Term Liabilities	$7.833M	$1.217M
YoY Change	543.63%	10.24%
Total Long-Term Liabilities	$356.0K	$1.217M
YoY Change	-70.75%	10.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.508M	$13.05M
Total Long-Term Liabilities	$356.0K	$1.217M
Total Liabilities	$17.70M	$17.07M
YoY Change	3.69%	-75.69%
SHAREHOLDERS EQUITY
Retained Earnings	-$740.3M	-$680.2M
YoY Change	8.84%	27.88%
Common Stock	$945.1M	$749.6M
YoY Change	26.09%	10.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$205.9M	$67.16M
YoY Change
Total Liabilities & Shareholders Equity	$223.6M	$84.23M
YoY Change	165.48%	-61.18%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	-$17.34M	-$16.60M
YoY Change	4.47%	-26.31%
Depreciation, Depletion And Amortization	$802.0K	$570.0K
YoY Change	40.7%	-5.0%
Cash From Operating Activities	-$10.24M	-$12.48M
YoY Change	-17.95%	-48.43%
INVESTING ACTIVITIES
Capital Expenditures	$395.0K	$2.000K
YoY Change	19650.0%	-98.31%
Acquisitions
YoY Change
Other Investing Activities		$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$395.0K	-$2.000K
YoY Change	19650.0%	-100.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$159.6M	$24.70M
YoY Change	546.07%	-9493.16%
NET CHANGE
Cash From Operating Activities	-$10.24M	-$12.48M
Cash From Investing Activities	-$395.0K	-$2.000K
Cash From Financing Activities	$159.6M	$24.70M
Net Change In Cash	$148.9M	$12.17M
YoY Change	1122.81%	172.23%
FREE CASH FLOW
Cash From Operating Activities	-$10.24M	-$12.48M
Capital Expenditures	$395.0K	$2.000K
Free Cash Flow	-$10.63M	-$12.48M
YoY Change	-14.8%	-48.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4215000	USD
CY2020Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3934000	USD
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3053000	USD
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	232716797
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	232716797
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	116231072
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	116231072
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	233186653
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	USD
CY2021Q1	asxc	Period Of Service Sale Arrangement PeriodOfServiceSaleArrangement	P5Y
CY2021Q1	asxc	Period Of Service Sale Arrangement At Stated Service Price PeriodOfServiceSaleArrangementAtStatedServicePrice	P4Y
CY2021Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2083000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	600000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3112000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1738000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	-1029000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	-1138000	USD
CY2020Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4253000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	7000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3349000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2867000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2564000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	257000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1056000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	-0	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-29000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000	USD
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1965000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-143000	USD
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3992000	USD
CY2021Q1	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	0	USD
CY2020Q1	asxc	Restructuring And Other Charges RestructuringAndOtherCharges	858000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	14384000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	16014000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15413000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-17152000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1981000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	155000	USD
CY2021Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	52000	USD
CY2020Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	27000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17378000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17295000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-38000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-697000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-17340000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-16598000	USD
CY2021Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	-0	USD
CY2020Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	412000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17340000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17010000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-17340000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-16598000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1938000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-872000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19278000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17470000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
CY2021Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	204992000
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	28906000
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165245000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16363000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2306000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1115000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	11181000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10034000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	3593000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	6501000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	182325000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	34013000	USD
CY2021Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1149000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1166000	USD
CY2021Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	7656000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8813000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9179000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10342000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	288000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	307000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4234000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1164000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	193000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	186000	USD
CY2021Q1	us-gaap	Assets Assets	223615000	USD
CY2020Q4	us-gaap	Assets Assets	78258000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2327000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1965000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3830000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6301000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	892000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	789000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	2459000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1228000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9508000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10283000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	4193000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3936000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	356000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1587000	USD
CY2021Q1	asxc	Warrant Liability WarrantLiability	0	USD
CY2020Q4	asxc	Warrant Liability WarrantLiability	255000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3640000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	628000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	17697000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	16689000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	233000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	116000	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	944907000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	781397000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-740252000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-722912000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1030000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2968000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	205918000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61569000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	223615000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78258000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	61569000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1786000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	129322000	USD
CY2021Q1	asxc	Stock Issued During Period Value Stock Options And Warrants Exercised StockIssuedDuringPeriodValueStockOptionsAndWarrantsExercised	32732000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	1000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	214000	USD
CY2021Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55535000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1923000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11212000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	0	USD
CY2020Q1	asxc	Stock Issued During Period Value Exchange Of Shares For Warrants StockIssuedDuringPeriodValueExchangeOfSharesForWarrants	2470000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1923000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1938000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-17340000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	205918000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	162000	USD
CY2020Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	33000	USD
CY2020Q1	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	-0	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	340000	USD
CY2020Q1	us-gaap	Depreciation Depreciation	570000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2867000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2564000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1786000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-872000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-16598000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	67162000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-17340000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-16598000	USD
CY2021Q1	us-gaap	Depreciation Depreciation	802000	USD
CY2021Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-38000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-697000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	122000	USD
CY2020Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1981000	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	155000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	257000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1056000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1608000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1063000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	21000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	76000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	242000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	509000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2290000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-433000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	128000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	83000	USD
CY2021Q1	asxc	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	3037000	USD
CY2020Q1	asxc	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-130000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10237000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12477000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	395000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-395000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2000	USD
CY2021Q1	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	0	USD
CY2020Q1	asxc	Proceeds From Issuance Of Equity Net ProceedsFromIssuanceOfEquityNet	13525000	USD
CY2021Q1	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	129322000	USD
CY2020Q1	asxc	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	11212000	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	214000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	33000	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30497000	USD
CY2020Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	159605000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24704000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-108000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-51000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	148865000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12174000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17529000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10567000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	166394000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22741000	USD
CY2021Q1	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	0	USD
CY2020Q1	asxc	Transfer Of Inventory To Property And Equipment TransferOfInventoryToPropertyAndEquipment	1958000	USD
CY2021Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	191000	USD
CY2020Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2021Q1	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	2236000	USD
CY2020Q1	asxc	Reclassification Of Warrant Liability To Common Stock And Additional Paid In Capital ReclassificationOfWarrantLiabilityToCommonStockAndAdditionalPaidInCapital	0	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3427000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2020Q1	us-gaap	Stock Issued1 StockIssued1	2470000	USD
CY2021Q1	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	0	USD
CY2020Q1	asxc	Transfer Of In Process Research And Development To Intellectual Property TransferOfInProcessResearchAndDevelopmentToIntellectualProperty	2425000	USD
CY2021Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2020Q1	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	30000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-740300000	USD
CY2021Q1	asxc	Working Capital WorkingCapital	172800000	USD
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30500000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	165200000	USD
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Use of Estimates</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include impairment considerations for intangible assets, fair value estimates related to contingent consideration, warrant liabilities, stock compensation expense, revenue recognition, accounts receivable reserves, excess and obsolete inventory reserves, inventory classification between current and non-current, and deferred tax asset valuation allowances.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The COVID-<em style="font: inherit;">19</em> pandemic has caused significant social and economic restrictions that have been imposed in the United States and abroad, which has resulted in significant volatility in the global economy and led to reduced economic activity. In the preparation of these financial statements and related disclosures, the Company has assessed the impact that COVID-<em style="font: inherit;">19</em> has had on its estimates, assumptions, forecasts, and accounting policies. The Company continues to monitor closely the COVID-<em style="font: inherit;">19</em> pandemic impact on its estimates, assumptions and forecasts used in the preparation of its financial statements. As the COVID-<em style="font: inherit;">19</em> situation is unprecedented and ever evolving, future events and effects related to COVID-<em style="font: inherit;">19</em> cannot be determined with precision, and actual results could significantly differ from estimates or forecasts.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1100000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1200000	USD
CY2021Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Concentrations and Credit Risk</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s principal financial instruments subject to potential concentration of credit risk are cash and cash equivalents, including amounts held in money market accounts. The Company places cash deposits with a federally insured financial institution. The Company maintains its cash at banks and financial institutions it considers to be of high credit quality; however, the Company’s domestic cash deposits <em style="font: inherit;"> may </em>at times exceed the Federal Deposit Insurance Corporation’s insured limit. Balances in excess of federally insured limitations <em style="font: inherit;"> may </em><em style="font: inherit;">not</em> be insured. The Company has <em style="font: inherit;">not</em> experienced losses on these accounts, and management believes that the Company is <em style="font: inherit;">not</em> exposed to significant risks on such accounts.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company’s accounts receivable are derived from sales to customers located throughout the world. The Company evaluates its customers’ financial condition and, generally, requires <em style="font: inherit;">no</em> collateral from its customers. The Company provided reserves for potential credit losses and recorded <em style="font: inherit;">no</em> bad debt charges during the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2021 </em>and <em style="font: inherit;">2020.</em> The Company had <span style="-sec-ix-hidden:c73383246">two</span> customers who constituted 74% of the Company’s net accounts receivable as of <em style="font: inherit;"> March 31, 2021. </em>The Company had <span style="-sec-ix-hidden:c73383248">seven</span> customers who constituted 68% of the Company’s net accounts receivable at <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2020.</em> The Company had <span style="-sec-ix-hidden:c73383252">one</span> customer who accounted for 57% of revenue in the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2021 </em>and <span style="-sec-ix-hidden:c73383255">eleven</span> customers who accounted for 80% of revenue in the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2020.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1700000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1800000	USD
CY2020Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2083000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	600000	USD
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	300000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	100000	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3500000	USD
CY2020Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3100000	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	100000	USD
CY2020Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	100000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	200000	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3500000	USD
CY2021Q1	us-gaap	Revenue Recognition Leases Operating RevenueRecognitionLeasesOperating	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b>Senhance System Leasing</b></p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company enters into lease arrangements with certain qualified customers. Revenue related to arrangements including lease elements are allocated to lease and non-lease elements based on their relative standalone selling prices. Lease elements generally include a Senhance System, while non-lease elements generally include instruments, accessories, and services. For some lease arrangements, the customers are provided with the right to purchase the leased System at some point during and/or at the end of the lease term. In some arrangements lease payments are based on the usage of the System.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In determining whether a transaction should be classified as a sales-type or operating lease, the Company considers the following terms at lease commencement: (<em style="font: inherit;">1</em>) whether title of the Senhance System transfers automatically or for a nominal fee by the end of the lease term, (<em style="font: inherit;">2</em>) whether the present value of the minimum lease payments equals or exceeds substantially all of the fair value of the leased System, (<em style="font: inherit;">3</em>) whether the lease term is for the major part of the remaining economic life of the leased System, (<em style="font: inherit;">4</em>) whether the lease grants the lessee an option to purchase the leased System that the lessee is reasonably certain to exercise, and (<em style="font: inherit;">5</em>) whether the underlying System is of such a specialized nature that it is expected to have <em style="font: inherit;">no</em> alternative use to the Company at the end of the lease term. All such arrangements through <em style="font: inherit;"> March 31, 2021 </em>are classified as operating leases.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Revenue related to lease elements from operating lease arrangements is generally recognized on a straight-line basis over the lease term or based upon System usage and is presented as product revenue. Revenue related to lease elements from operating lease arrangements was approximately $0.3 million and $0.1 million for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2021 </em>and <em style="font: inherit;">2020,</em> respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	300000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	100000	USD
CY2021Q1	us-gaap	Inventory Write Down InventoryWriteDown	100000	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1800000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	165245000	USD
CY2021Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1149000	USD
CY2021Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	166394000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	4193000	USD
CY2021Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4193000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	16363000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1166000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	17529000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	3936000	USD
CY2020Q4	asxc	Warrant Liability WarrantLiability	255000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	4191000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	300000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1100000	USD
CY2017Q2	asxc	Number Of Units Sold NumberOfUnitsSold	24900000
CY2017Q2	asxc	Number Of Shares In Each Unit NumberOfSharesInEachUnit	0.077
CY2017Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1.00
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2000000.0	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	200000	USD
CY2021Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2000000.0	USD
CY2020Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	200000	USD
CY2021Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	11841000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10749000	USD
CY2021Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6996000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8098000	USD
CY2021Q1	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18837000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18847000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	11181000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	10034000	USD
CY2021Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	7656000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	8813000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	839000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	576000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	477000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	484000	USD
CY2021Q1	asxc	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	2931000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5984000	USD
CY2021Q1	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18837000	USD
CY2020Q4	asxc	Inventory Current And Noncurrent Net InventoryCurrentAndNoncurrentNet	18847000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	69238000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	52637000	USD
CY2021Q1	asxc	Finite Lived Intangible Assets Foreign Currency Translation Impact FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact	1990000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18591000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	69238000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	51902000	USD
CY2020Q4	asxc	Finite Lived Intangible Assets Foreign Currency Translation Impact FiniteLivedIntangibleAssetsForeignCurrencyTranslationImpact	4931000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22267000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.002	pure
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.038	pure
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0.0	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	700000	USD
CY2021Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-40000.00	USD
CY2020Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	20000.00	USD
CY2020	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	300000	USD
CY2021Q1	asxc	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	45114210
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	30500000	USD
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8743586
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	800000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3600000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	400000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	400000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	400000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	677000	USD
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	53819880
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.079	pure
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.082	pure
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4200000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4400000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1605000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	4379000	USD

Files In Submission

Name	View Source	Status
0001437749-21-011716-index-headers.html	Edgar Link	pending
0001437749-21-011716-index.html	Edgar Link	pending
0001437749-21-011716.txt	Edgar Link	pending
0001437749-21-011716-xbrl.zip	Edgar Link	pending
asxc-20210331.xsd	Edgar Link	pending
asxc-20210331_cal.xml	Edgar Link	unprocessable
asxc-20210331_def.xml	Edgar Link	unprocessable
asxc-20210331_lab.xml	Edgar Link	unprocessable
asxc-20210331_pre.xml	Edgar Link	unprocessable
ex_247122.htm	Edgar Link	pending
ex_247123.htm	Edgar Link	pending
ex_247124.htm	Edgar Link	pending
ex_247125.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
transe20210331_10q.htm	Edgar Link	pending
transe20210331_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TRXDW
Stock $trxdw

2021 Q1 Form 10-Q Financial Statement

#000143774921011716 Filed on May 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRXDW Stock $trxdw

2021 Q1 Form 10-Q Financial Statement

#000143774921011716 Filed on May 11, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TRXDW
Stock $trxdw